AOP 3.13% 33.0¢ apollo consolidated limited

Biocon Ltd, an indian biotech company are developingan oral...

  1. 89 Posts.
    lightbulb Created with Sketch. 12
    Biocon Ltd, an indian biotech company are developing
    an oral insulin.1N-105 is a novel analog of insulin.
    Phase 1 studies show promising results.
    A potential competitor for aop.
 
watchlist Created with Sketch. Add AOP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.